Patients with CLL with an abnormal sFLC ratio were significantly more likely to have U-IgVH, a Zap-70 positivity, a lymphocyte doubling time less than 12 months, and a high β2-microglobulin. The gene discussed is HLA-G; the disease is B-cell chronic lymphocytic leukemia.